U2AF1 and myelodysplastic syndrome: In addition to MDS patients with DDX41 mutations (n = 8), MDS patients with SF mutations (n = 4, U2AF1 mutations in all) and non-DDX41/SF mutations (n = 7) were also included based on previous studies of R-loop in MDS patients [16, 17].